位置:成果数据库 > 期刊 > 期刊详情页
小檗碱及其衍生物对2型糖尿病大鼠骨骼肌PTP1B蛋白表达的影响
  • ISSN号:1001-5213
  • 期刊名称:中国医院药学杂志
  • 时间:2012
  • 页码:1430-1434
  • 分类:R285.5[医药卫生—中药学;医药卫生—中医学]
  • 作者机构:[1]华中科技大学同济医学院附属同济医院中西医结合研究所,湖北武汉430030, [2]华中科技大学同济医学院附属同济医院药学部,湖北武汉430030
  • 相关基金:国家自然基金项目(编号:81173370,30973836)
  • 相关项目:基于黄连粉末中Hdber的追踪研究探讨黄连粉末治疗消渴症的科学内涵
中文摘要:

目的:观察小檗碱及其衍生物对2型糖尿病大鼠骨骼肌蛋白酪氨酸磷酸酯酶1B(PTP1B)蛋白表达的影响。方法:采用尾静脉注射小剂量链脲佐菌素(STZ)和高脂高热卡饮食喂养的方法建立大鼠2型糖尿病模型。随机分为模型组、小檗碱组、8-羟基二氢小檗碱(Hdber)高、中、低剂量组和二甲双胍组,另设正常对照组。干预8周后,检测各组大鼠血糖、血脂、空腹胰岛素(FINS)水平及骨骼肌PTP1B、胰岛素受体β(InsRβ)亚基蛋白及其酪氨酸磷酸化水平的差异。结果:与正常组比较,模型组大鼠血糖升高,血脂代谢紊乱,FINS及骨骼肌PTP1B蛋白表达升高(P〈0.05,P〈0.01),而InsRβ亚基蛋白表达及其酪氨酸磷酸化水平降低(P〈0.01);与模型组比较,各治疗组代谢紊乱均得到明显改善、FINS降低(P〈0.05,P〈0.01),但骨骼肌组织PTP1B蛋白表达水平无明显差异;与小檗碱组比较,Hdber中高剂量组对各指标的改善程度相接近。结论:小檗碱及Hdber均可改善2型糖尿病大鼠糖脂代谢紊乱,其机制可能与增加骨骼肌组织InsRβ亚基蛋白表达及其酪氨酸磷酸化水平有关,而未观察到其对PTP1B蛋白表达水平的显著影响。

英文摘要:

OBJECTIVE To explore the effects of berberine and its derivatives on the expression of PTP1B protein in skeletal tissues of type 2 diabetic rats.METHODS The rat model of type 2 diabetes was established by intravenous injection of small doses of streptozotocin and feeding a high-fat diet for 8 weeks.The rats were randomly divided into diabetic group,berberine group,8-hydroxy dihydroberberine(Hdber) groups with different doses,and metformin group.Meanwhile,another normal group of rats was established as control.After eight weeks treatment,blood glucose,plasma lipid profiles,fasting plasma insulin(FINS) levels,the expressions of PTP1B,insulin receptorβ(InsRβ) protein and phospho-tyrosine level of InsRβ in skeletal tissues were detected.RESULTS Compared with the control group,the plasma glucose,serum lipids and FINS in diabetic group were elevated.Skeletal expression of PTP1B protein was increased,while InsRβ protein and its phospho-tyrosine level were decreased significantly(P〈0.05,P〈0.01).Compared with model group,the addition of berberine or Hdber reversed the above abnormalities(P〈0.05,P〈0.01) except skeletal expression of PTP1B protein was not significantly changed.The difference of the hypoglycemic and lipid-regulating effects between berberine group and high and middle doses Hdber groups were hardly observed.CONCLUSION Berberine and its derivative are effective on regulating glucose and lipid metabolism disturbance in type 2 diabetic rats.The therapeutic mechanism is possibly related to the increase of the expression of InsRβ protein and its phospho-tyrosine level,and the influence of berberine and its derivative on the expression of PTP1B protein in skeletal tissue was not demonstrated.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国医院药学杂志》
  • 北大核心期刊(2011版)
  • 主管单位:中国科学技术协会
  • 主办单位:中国药学会
  • 主编:陈华庭
  • 地址:武汉市汉口胜利街155号
  • 邮编:430014
  • 邮箱:pharmacy@vip.163.com
  • 电话:027-82836596
  • 国际标准刊号:ISSN:1001-5213
  • 国内统一刊号:ISSN:42-1204/R
  • 邮发代号:38-50
  • 获奖情况:
  • 曾获中国药学会优秀期刊二等奖,中国科协优秀期刊三等奖,湖北省优秀期刊奖
  • 国内外数据库收录:
  • 美国国际药学文摘,美国化学文摘(网络版),日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),中国北大核心期刊(2000版)
  • 被引量:53772